Lexicon Pharmaceuticals (LXRX) Assets (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Assets of $268.8 million for Q1 2026, down 9.69% year-over-year from $297.7 million in Q1 2025, and up 45.32% quarter-over-quarter from $185.0 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Assets (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Assets for 17 consecutive years, with $268.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 9.69% year-over-year to $268.8 million; the TTM figure through Mar 2026 stood at $268.8 million (down 9.69% YoY), while the FY2025 annual figure was $185.0 million, down 38.01% from the prior year.
- Assets advanced to $268.8 million in Q1 2026 per LXRX's latest filing, from $185.0 million in the prior quarter.
- Across five years, Assets topped out at $417.2 million in Q1 2024 and bottomed at $112.3 million in Q2 2022.
- Historically, Assets has averaged $247.8 million across 5 years, with a median of $229.4 million in 2023.
- Annual changes were most pronounced in 2023 — Assets soared 181.97% — and 2025, when it sank 39.58%.
- Lexicon Pharmaceuticals' Assets stood at $194.3 million in 2022, then gained by 18.08% to $229.4 million in 2023, then jumped by 30.07% to $298.4 million in 2024, then slumped by 38.01% to $185.0 million in 2025, then soared by 45.32% to $268.8 million in 2026.
- Business Quant data shows LXRX's Assets at $268.8 million in Q1 2026, $185.0 million in Q4 2025, and $205.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | 250.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 250.06 Mn |
| Mar 31, 2026 | 268.82 Mn |
| Dec 31, 2025 | 184.99 Mn |
| Sep 30, 2025 | 205.93 Mn |
| Jun 30, 2025 | 225.58 Mn |
| Mar 31, 2025 | 297.67 Mn |
| Dec 31, 2024 | 298.42 Mn |
| Sep 30, 2024 | 321.12 Mn |
| Jun 30, 2024 | 373.36 Mn |
| Mar 31, 2024 | 417.22 Mn |
| Dec 31, 2023 | 229.43 Mn |
| Sep 30, 2023 | 276.48 Mn |
| Jun 30, 2023 | 316.72 Mn |
| Mar 31, 2023 | 162.72 Mn |
| Dec 31, 2022 | 194.30 Mn |
| Sep 30, 2022 | 191.69 Mn |
| Jun 30, 2022 | 112.33 Mn |
| Mar 31, 2022 | 136.18 Mn |
| Dec 31, 2021 | 136.91 Mn |
| Sep 30, 2021 | 172.33 Mn |